A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants
Clinical trial NCT02555878 · COMPLETED
Trial details
- NCT number
- NCT02555878
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-11
- Primary completion
- 2018-08-24
- Enrollment
- 841
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.